Sculati Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Buy
3,521
+246
+8% +$87.7K 0.46% 61
2025
Q4
$1.07M Buy
3,275
+38
+1% +$12.1K 0.38% 64
2025
Q3
$913K Buy
3,237
+818
+34% +$237K 0.32% 74
2025
Q2
$675K Buy
+2,419
New +$685K 0.25% 78

Other funds holding AMGN

Sculati Wealth Management's AMGN Position: Q1 2026 in Review

Sculati Wealth Management increased its Amgen (AMGN) stake by 7.5% in Q1 2026, buying an estimated $87.7K and bringing the position to 3,521 shares worth $1.24M. The position accounts for 0.46% of the portfolio, ranked #61.

Sculati Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Sculati Wealth Management held 3,521 shares of Amgen worth $1.24M as of Q1 2026.
  • Sculati Wealth Management bought 246 Amgen shares in Q1 2026, an estimated $87.7K.
  • Amgen made up 0.46% of Sculati Wealth Management's portfolio in Q1 2026, its #61 holding.
  • Sculati Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sculati Wealth Management's 13F filing for Q1 2026, filed 9 Apr 2026.